Table 4 Multiple logistic regression analysis of CAD and multivessel lesion risk in males and females

Total

737

<0.001

<0.001

 Female

325

1.657(0.958-2.865)

0.071

1.550(0.920-2.613)

0.100

 Male

412

7.539(4.032-14.097)

<0.001

2.958(1.801-4.858)

<0.001

HbA1c ≥ 7.5

300

<0.001

<0.001

 Female

119

1.384(0.469-4.086)

0.556

1.334(0.510-3.492)

0.557

 Male

181

13.503(4.138-44.067)

<0.001

5.369(2.206-13.068)

<0.001

HbA1c<7.5

437

<0.001

<0.001

 Female

206

1.605(0.800-3.217)

0.183

1.683(0.859-3.295)

0.129

 Male

231

7.976(3.450-18.441)

<0.001

2.199(1.157-4.180)

0.016

Age ≥ 65

303

<0.001

0.008

 Female

171

1.455(0.638-3.317)

0.372

1.484(0.712-3.091)

0.292

 Male

132

9.277(1.715-50.173)

0.010

1.831(0.614-5.459)

0.278

Age<65

434

<0.001

<0.001

 Female

154

2.271(0.972-5.310)

0.058

2.097(0.903-4.870)

0.085

 Male

280

8.654(3.977-18.831)

<0.001

3.457(1.432-4.562)

<0.001

Using antidiabetic/or insulin

486

<0.001

<0.001

 Female

216

1.238(0.622-2.463)

0.543

1.299(0.684-2.467)

0.424

 Male

270

10.368(4.429-24.273)

<0.001

3.438(1.823-6.485)

<0.001

Not using antidiabetic/or insulin

251

<0.001

<0.001

 Female

109

1.587(0.505-4.989)

0.430

1.525(0.467-4.982)

0.485

 Male

142

11.856(3.082-45.614)

<0.001

2.883(1.086-7.659)

0.034